Neil L. Berinstein, M.D. Joins IRX Team IRX Therapeutics appoints Neil L. Berinstein, M.D. Chief Scientific Officer IRX Presents Phase 2 Results IRX Therapeutics to Present Phase 2 Results at 7th International Conference on Head and Neck Cancer IRX Therapeutics to Present Phase 2b Results IRX Therapeutics to Present Phase 2b Results at 3rd European Conference on Head & Neck Oncology
